ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents
- PMID: 21126648
- DOI: 10.1016/j.jacc.2010.09.010
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents
Similar articles
-
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.Circulation. 2008 Oct 28;118(18):1894-909. doi: 10.1161/CIRCULATIONAHA.108.191087. Epub 2008 Oct 3. Circulation. 2008. PMID: 18836135 No abstract available.
-
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17. doi: 10.1016/j.jacc.2008.08.002. J Am Coll Cardiol. 2008. PMID: 19017521 No abstract available.
-
[The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].Recenti Prog Med. 2009 May;100(5):277-8. Recenti Prog Med. 2009. PMID: 19772220 Italian. No abstract available.
-
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.Circulation. 2010 Dec 14;122(24):2619-33. doi: 10.1161/CIR.0b013e318202f701. Epub 2010 Nov 8. Circulation. 2010. PMID: 21060077 Review. No abstract available.
-
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.Am J Gastroenterol. 2010 Dec;105(12):2533-49. doi: 10.1038/ajg.2010.445. Am J Gastroenterol. 2010. PMID: 21131924 Review. No abstract available.
Cited by
-
Physicians' perceptions and awareness of adverse effects of proton pump inhibitors and impact on prescribing patterns.Front Pharmacol. 2024 Jun 26;15:1383698. doi: 10.3389/fphar.2024.1383698. eCollection 2024. Front Pharmacol. 2024. PMID: 38989150 Free PMC article.
-
Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view.World J Cardiol. 2023 Aug 26;15(8):375-394. doi: 10.4330/wjc.v15.i8.375. World J Cardiol. 2023. PMID: 37771340 Free PMC article. Review.
-
Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction.Pharmaceuticals (Basel). 2023 Aug 28;16(9):1213. doi: 10.3390/ph16091213. Pharmaceuticals (Basel). 2023. PMID: 37765021 Free PMC article.
-
Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study.CMAJ Open. 2023 Feb 28;11(1):E170-E178. doi: 10.9778/cmajo.20210240. Print 2023 Jan-Feb. CMAJ Open. 2023. PMID: 36854455 Free PMC article. Clinical Trial.
-
Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events.Cardiovasc Drugs Ther. 2022 Dec;36(6):1121-1128. doi: 10.1007/s10557-021-07219-6. Epub 2021 Jul 9. Cardiovasc Drugs Ther. 2022. PMID: 34241731 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
